Computational, Cognitive and Clinical Neuroimaging Laboratory (C3NL)

Activity: Participating in or organising an event typesParticipation in workshop, seminar, course


Title: Neurocognitive markers for Alzheimer’s disease


Current approaches to fight Alzheimer's disease (AD) focus on (1) detecting the disease earlier, (2) slowing cognitive decline, and (3) retaining quality of life. Recent guidelines and consensus papers draw our attention towards the preclinical stages where current assessment and intervention strategies are not meeting the needs. I will discuss (1) recent evidence calling for a paradigm shift in the assessment of memory functions in people at risk of AD. (2) Current research aimed at understanding how assessment of such memory functions combined with neuroscience methods can gather biological evidence and thus yield affordable cognitive biomarkers of AD. (3) Recent research that incorporates theories of cognitive decline in AD into technology driven assessments and interventions.

Period7 Nov 2019
Event typeSeminar
LocationLondon, United Kingdom
Degree of RecognitionNational